![](/img/cover-not-exists.png)
Early Suppression of the Serological Macrophage Activity Biomarker VICM, and not Suppression of CRP, Predicts the Response to Infliximab in Crohn's Disease Patients
Mortensen, Joachim Hog, van Haaften, Wouter T., Olesen, Majken Lindholm, Karsdal, Morten Asser, Olinga, Peter, Dijkstra, Gerard, Bay-Jensen, Anne-ChristineVolume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(17)31521-4
Date:
April, 2017
File:
PDF, 1.34 MB
english, 2017